- Basis of preparationFY
- Going concern
- Material uncertainty
- None disclosed
- Viability statement horizon
- 5 years
“A five-year period is considered appropriate for this review as this corresponds with the Company's strategic planning timeframe.”
| Disclosure | Value |
|---|---|
| Disclosure | Value |
|---|---|
“A five-year period is considered appropriate for this review as this corresponds with the Company's strategic planning timeframe.”
Figures read from the report text and not reconciled against tagged iXBRL data. Treat them as indicative and check the source document.
Contractual cash flows, undiscounted — these include future interest and so exceed the carrying amounts above.
Extracted from filed annual reports. Disclosures are point-in-time and each section is labelled with the financial year it came from; always check the source document before acting on anything here.
“A five-year period is considered appropriate for this review as this corresponds with the Company's strategic planning timeframe.”
Figures read from the report text and not reconciled against tagged iXBRL data. Treat them as indicative and check the source document.
Contractual cash flows, undiscounted — these include future interest and so exceed the carrying amounts above.
Extracted from filed annual reports. Disclosures are point-in-time and each section is labelled with the financial year it came from; always check the source document before acting on anything here.
| Facility | Size | Drawn | Undrawn | Matures |
|---|---|---|---|---|
| Assura public bond 2028 | £300m | — | — | |
| Assura public bond 2030 | £300m | — | — | |
| Assura public bond 2033 | £300m | — | — | |
| Assura US private placement 2034 | £60m | — | — | |
| €120 million Euro private placement 2032 | €105m | — | — | |
| Secured bond March 2027Secured | £100m | — | — | |
| €51 million Euro private placement December 2028–30Secured | €44m | — | — | |
| €70 million Euro private placement September 2031Secured | €61m | — | — | |
| €75 million Euro private placement February 2034Secured | €65m | — | — | |
| €47 million Euro private placement December 2033Secured | €42m | — | — | |
| Ignis loan note December 2028Secured | £50m | — | — | |
| Standard Life loan note September 2028Secured | £78m | — | — |
| Facility | Size | Drawn | Undrawn | Matures |
|---|---|---|---|---|
| Assura public bond 2028 | £300m | — | — | |
| Assura public bond 2030 | £300m | — | — | |
| Assura public bond 2033 | £300m | — | — | |
| Assura US private placement 2034 | £60m | — | — | |
| €120 million Euro private placement 2032 | €105m | — | — | |
| Secured bond March 2027Secured | £100m | — | — | |
| €51 million Euro private placement December 2028–30Secured | €44m | — | — | |
| €70 million Euro private placement September 2031Secured | €61m | — | — | |
| €75 million Euro private placement February 2034Secured | €65m | — | — | |
| €47 million Euro private placement December 2033Secured | €42m | — | — | |
| Ignis loan note December 2028Secured | £50m | — | — | |
| Standard Life loan note September 2028Secured | £78m | — | — |